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Abstract
The correlation between epigenetics and human reproduction represents a very interesting field of study, mainly
due to the possible transgenerational effects related to epigenetic modifications of male and female gametes. In
the present review, we focused our attention to the role played by epigenetics on male reproduction, evidencing
at least four different levels at which sperm epigenetic modifications could affect reproduction: (1) spermatogenesis
failure; (2) embryo development; (3) outcome of assisted reproduction technique (ART) protocols, mainly as
concerning genomic imprinting; and (4) long-term effects during the offspring lifetime. The environmental agents
responsible for epigenetic modifications are also examined, suggesting that the control of paternal lifestyle prior to
conception could represent in the next future a novel hot topic in the management of human reproduction.
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Background
You shall not bow down to them or worship them;
for I, the Lord your God, am a jealous God,
punishing the children for the sin of the parents
to the third and fourth generation of those who hate me
(Esodus, 20.5)
Infertility represents a growing emergency in western
countries, affecting about one out of seven couples who
attempt to generate a child. In 2010, an estimated 48.5
million couples worldwide were infertile, against 42 mil-
lion in 1990 [1]. In about 50 % of the cases, this condi-
tion is ascribable to the male partner, mainly due to a
failure in the spermatogenesis process causing azoosper-
mia or oligozoospermia at the sperm count [2]. Despite
the large number of tools available for the identification
of the pathogenesis of male infertility, in many cases, no
specific cause is detected and no personalized thera-
peutic protocol can be established. A large number of
studies have investigated in the last decades the presence
of genetic alterations responsible for the failure of
spermatogenesis, which are nevertheless identified only
in 15–30 % of infertile males, even when stringent selec-
tion criteria are used [3, 4]. Despite the identification of
several rare genetic variants associated to disruption of
spermatogenesis, so far, the only two categories of
genetic alterations responsible for a significant portion
of cases of male infertility, and thus commonly tested in
the clinical practice, are represented by chromosomal
alterations and Yq microdeletions [5–10]. The presence
of other genetic mechanisms, such as partial Yq
microdeletions [11–14], specific Y-chromosome hap-
logroups [15–18], and polymorphism in genes related
to mitochondrial function [19–21] as risk factors for
infertility have been suggested, but with inconclusive
results. More recently, the presence of X-linked copy
number variants (CNVs) in infertile males has been
reported by several studies [22, 23], but the overall
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incidence of these variants accounts only for a limited
portion of all cases.
In recent years, great interest has been raised by the
novel acquisitions on the epigenetic mechanisms of
regulation of gene expression. Epigenetics can be defined
as the study of mitotically or meiotically heritable modi-
fications in the function of specific genes not related to
modification in the DNA sequence [24]. This novel field
of study has obtained large relevance also in the world
of mass media, usually transmitting the “take-home
message” that human destiny is not written inside genes,
since environmental agents or experiences can influence
human heredity [25]. As a matter of fact, the interaction
between genes and environment in the determination of
human phenotypes is very well known from many years,
but the real novelties provided by the studies on epigen-
etics are that (1) environmental agents can modify the
expression of specific genes without changing their
sequence or copy number, and (2) these modifications
can be transmitted to the offspring, so that either rare
congenital diseases or the susceptibility to common
diseases appearing during the lifetime can be the result
of a gene-environment interaction that occurred in one
parent of a subject, not in the subject himself. In this
view, epigenetic studies represent a breakthrough in the
field of human reproduction. In fact, since epigenetic
modifications can be transmitted to the offspring,
they obviously involve germ cells, and in some cases,
they could affect gametogenesis as well as the embryo
development, thus representing a potential cause of
infertility of the couple. Moreover, since epigenetic
alterations do not induce modification in the gene
sequence or copy number, they could account for at
least a portion of cases of male infertility in which no
genetic abnormalities are detected using the conven-
tional techniques of genetic analysis.
Several studies have investigated in the last years the
role played by epigenetic modification in male gameto-
genesis and in male infertility. The aim of this review is
to analyze the state-of-art of this field of research in
order to give an answer to the following questions. (1)
Can epigenetic mechanisms be related to the quality of
the spermatogenesis process? (2) Can sperm epigen-
etic alterations affect embryo development? (3) Is
there a relationship between sperm epigenetic modifi-
cations and outcome of assisted reproduction tech-
nique (ART) procedure? (4) Which environmental
agents can be responsible for epigenetic modifications
of sperm DNA?
Molecular basis of epigenetics
The main epigenetic mechanisms of gene expression
regulation are represented by DNA methylation, histone
modifications, and small, non-coding RNAs.
DNA methylation
In mammalians, DNA methylation occurs at the 5′- pos-
ition of cytosine residues, mainly within CpG dinucleo-
tides, 60–80 % of which are methylated within the
promoter regions of genes [24]. Methylation of CpG
dinucleotides within the promoter regions leads to the
silencing of transcription process, mediated by modifica-
tions in the condensation status of the chromatin. The
process of DNA methylation is catalyzed by enzymes
known as DNA methyltransferases (DNMTs), which can
be classified in “de novo” DNMTs (which methylate
specific chromosomal sequences during early embryo-
genesis), and maintenance methyltransferases (DNMT1),
faithfully restoring the methylation patterns after each
DNA replication cycle [26]. The process of DNA methyla-
tion is closely related with gametogenesis, since primordial
germ cells (PGCs), when entering the developing gonad,
undergo a process of deep decrease of DNA methylation,
which will be subsequently restored in the prenatal life in
males and during post-natal follicle development in
females (Fig. 1) [27].
Cytosine methylation can occur also in non-CpG sites
(CpA > CpT > CpC), although the significance of these
variants is still unknown. Methylation at non-CpG sites
was previously considered to be largely present in the
brain, embryonic stem cells (ESCs), induced pluripotent
stem cells, and in oocytes [28–32]. However, Ichiyanagi
et al. observed methylation at non-CpG sites in male
germ cells as well, demonstrating that the level of the
non-CpG methylation is higher in prospermatogonia
and decreases along with mitotic division. In addition,
this study also suggested the absence of a template-
dependent mechanism for copying non-CpG methyla-
tion in prospermatogonia [33].
Another kind of epigenetic DNA modification is
represented by 5-hydroxymethylcytosine (5hmC), an
intermediate of DNA demethylation with important
regulatory functions in various biological and patho-
logical processes in the mammalian genome such as
transcriptional regulation, DNA methylation regula-
tion, and tumorigenesis [34]. Gan et al. showed that
the highly ordered 5hmC alterations are critical for
the differentiation of spermatogenic cells in the mouse
[35]. Recently, Wang et al. for the first time compared
5-hydroxymethylcytosine profiles in normal, abnor-
mal, and globozoospermia sperms, identifying 6664,
9029, and 6318 genes containing 5hmC, respectively
[36]. In addition, since some 5hmC-containing genes
are significantly involved in spermatogenesis, sperm
motility, and morphology, the authors suggested that
the 5hmC distribution differences may contribute to
the sperm phenotype [36].
DNA methylation was originally investigated by
Southern blot and methylation-sensitive restriction
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endonuclease digestion followed by PCR amplification
[37]. Nowadays, gene-specific techniques are available
including bisulfite sequencing, combined bisulfite
restriction analysis (COBRA) [38], MethyLight [39],
and bisulfite pyrosequencing [40], all based on bisul-
fite conversion of cytosine residue to uracil, leaving 5-
methylcytosine residue unaffected [41], detectable by
DNA sequencing. All the abovementioned techniques
are sensitive, specific, and relatively inexpensive but
not suitable for analysis of the whole genome, which
includes about 28 million CpGs.
The next-generation sequencing (NGS) approach
represents a new powerful tool for the study of human
DNA methylome [42]. The NGS DNA methylation
procedures are based on three main steps: digestion of
genomic DNA with methyl-sensitive restriction enzymes,
affinity-based enrichment of methylated DNA fragments,
and chemical conversion methods [43, 44].
Another large-scale approach is represented by whole-
genome bisulfite sequencing (WGBS), which is able to
analyze DNA methylation profiles of whole genomes at
single-base resolution [45]. Recently, several studies have
reported WGBS accurate data on methylome both of
human embryonic stem cells [46] and induced pluripo-
tent stem cells [47].
Histone modifications
Modifications of histone tails represent other epigenetic
chromatin marks critical for transcriptional regulation.
Post-translational modifications of histone tails include
methylation, acetylation, phosphorylation, ubiquitina-
tion, ribosylation, and sumoylation. Histone marks are
dynamic process, since histone modifications can be
easily induced and removed by a wide range of enzymes
[48]. The most relevant histone change is represented by
acetylation at lysine residues on the amino-terminal tail
domains, whose correct levels are maintained by the
combined action of two enzymes known as histone acetyl
transferase (HAT) and histone deacetylase (HDAC).
Generally, acetylation reduces the affinity of histones for
DNA, making genes functionally active; on the other
hand, histone deacetylation leads to chromatin condensa-
tion, making genes transcriptionally inactive. Conversely,
histone methylation is a key regulator for both activation
and inactivation of transcription. For example, lysine 4 of
histone H3 (H3-K4) methylation is linked to gene expres-
sion, while H3K9 and H3K27 di- and tri-methylation is
associated with gene silencing [49, 50].
Histone H3T is the testis-specific H3 variant in
mammals. Tachiwana et al. showed that H3T nucleo-
somes can be assembled by Nap2 chaperone and that
Fig. 1 Epigenetic modifications during spermatogenesis. During the different steps of spermatogenesis, several epigenetic modifications involving
DNA methylations and histone modifications occur. (1) PGCs undergo a process of demethylation involving DNA (with erasure of genomic imprinting)
and histones (namely, K4 and K9 residues of H3). Also, a process of H4 deacetylation is present. DNMT3A, DNMT3B, and DNMT3L are expressed at this
time. (2) In spermatogonia, a progressive DNA methylation occurs, with establishment of paternal methylation. (3) In spermatocytes, H3K9 and H3K4
methylation is observed. (4) In round spermatids, H4 becomes hyperacetylated, DNMT1 is expressed, and the transition from histones to TPs occurs.
(5) Elongated spermatids show a maintenance of DNA methylation, together with H3K9 demethylation. The transition from TPs to protamines occurs
at this step. (6) In spermatozoa, the genomic imprinting is maintained
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this structure is significantly unstable as compared to the
conventional H3.1-containing nucleosomes [51, 52].
Furthermore, these authors suggested that the unstable
H3T-containing nucleosome structure can influence
the chromatin re-organization essential for spermato-
genesis [52].
Histone modifications were originally investigated by
Western blot with specific antibodies to modified
histones, but nowadays, they are mainly studied by
mass-spectrometry-based proteomic technologies [53].
Recently, NGS technologies have been developed able to
analyze whole-genome histone modifications. These
techniques are based on chromatin immunoprecipitation
followed by sequencing maps of the genome-wide bind-
ing pattern of chromatin-associated proteins, which
includes modified histones (ChIP-seq) [44, 54].
Small non-coding RNAs
A third mechanism of epigenetic regulation of gene
activity is represented by small RNAs and large inter-
genic non-coding RNAs (lincRNAs). Small RNAs, not
encoding proteins, are located in the nucleus of sperm-
atozoa and play an essential role as epigenetic modifiers
both in recognizing and preserving the DNA that
remains bound to histones during the transition to
protamine in spermiogenesis and in early embryonic
development [55]. On the other hand, lincRNAs act at
the level of chromatin allowing to select the histone
modification enzymes, such as in the case of lincRNAs
HOTAIR which acts as a scaffold for PRC2 and LSD1
enzymes to regulate lysine 27 methylation and lysine 4
demethylation in H3 histone [56].
Small non-coding RNAs are generally identified by
RT-PCR analysis, in situ hybridization, or small RNA
sequencing studies. Furthermore, the recent develop-
ment of microarray technologies has permitted the
global analysis of spermatozoal microRNAs (miRNAs)
evidencing different expression profiles between fertile
and infertile men [57, 58].
Genomic imprinting
A specific feature of epigenetic control of gene function
is represented by genomic imprinting, a process leading
to the expression of a specific set of genes (about 70–80,
the majority of which clustered in 16 specific chromo-
somal regions) based on their maternal or paternal
origin [59]. Genomic imprinting plays a key role in the
regulation of resource acquisition by the offspring from
the mother during prenatal and early postnatal life.
Paternally and maternally imprinted genes play different
roles in this mechanism, being many paternally expressed
alleles able to increase resource transfer to the child,
which is on the other side reduced by maternally
expressed genes (“parental conflict hypothesis”) [60]. The
correct balance between the activity of maternally and
paternally imprinted genes can be disrupted by different
mechanisms, such as chromosome deletions, uniparental
disomy (UPD), or alterations in the imprinting center. In
human, alterations of the process of genomic imprint-
ing cause several congenital diseases mainly involving
fetal growth (e.g., Beckwith–Wiedemann syndrome,
Russell–Silver syndrome), hormone systems after birth
(e.g., Albright hereditary osteodystrophy, pseudohypo-
parathyroidism 1A, transient neonatal diabetes mellitus),
or behavior (e.g., Prader–Willi syndrome, Angelman
syndrome) [60]. Moreover, imprinting alterations have
been suggested as responsible for intrauterine growth
restriction, in turn associated with an increased risk of
cardiovascular disease, diabetes, and mental defects later
in life [60, 61].
The discovery of the role played by epigenetic modifi-
cations on the function of paternal genome has
prompted novel attention on the function of sperm
DNA during embryo development. In fact, sperms have
been historically viewed as specialized cells with the
unique function of delivering the 23 paternal chromo-
somes to the oocyte, considered as the only gamete
playing an active role in driving embryo development,
thanks to its availability of cellular organelles, RNAs,
and cellular machinery. Actually, the role played by the
male gamete in embryo development appears to be
more relevant than previously hypothesized. In this
view, a full knowledge of the epigenetics of sperm could
provide novel information about germ cell biology,
paternal effects on embryogenesis, and the pluripotency
of embryonic stem cells [62].
Epigenetics and spermatogenesis
The process of spermatogenesis
The formation of a mature sperm requires different
processes, namely (1) mitotic proliferation of spermato-
gonia; (2) meiotic divisions; and (3) morphological differ-
entiation of sperm precursors (spermiogenesis), leading
to the generation of highly specialized cells characterized
by the presence of a head, an intermediate portion, and
a flagellum. Such a specific organization of the male
germ cells is necessary to allow sperms to traverse a po-
tentially hostile female reproductive tract, penetrate the
cumulus oophorus and the zona pellucida, penetrate the
oocyte, and finally complete multiple post-penetration
events [62, 63]. During fetal life, spermatogenesis begins
in the wall of the seminiferous tubules from undiffer-
entiated diploid cells known as spermatogonia, which
undergo several mitotic divisions in order to increase
the pool of available precursors of germ cells. At
puberty, some spermatogonia are transformed in type
I spermatocytes, which undergo the first meiotic
division producing haploid type II spermatocytes. A
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second meiotic division occurs in these cells, originating
haploid spermatids. The last phase of spermatogenesis is
represented by spermiogenesis, characterized by a mor-
phological and structural transformation complex process
of the round spermatid. This step, occurring without
further cell division, leads to the production of mature
sperm, characterized by the differentiation of the flagellum
and the acrosome, essential prerequisites for sperm motil-
ity and fertilization capacity.
Histone–protamine replacement as the main epigenetic
change in sperms
In addition to the typical morphology and motility, sperms
are characterized also by a highly organized chromatin
structure. In fact, sperm chromatin during spermiogenesis
undergoes further condensation, due to the replacement
of 90–95 % of the histones with one or more sperm-
specific basic proteins, known as protamines [64]. This
modification induces the formation of disulfide bonds (SS)
that confer extreme stability to the core of the sperm
nucleus, producing a number of relevant effects, such as
improvement of sperm motility, protection from oxidative
stress and toxic agents present within female reproductive
tract, and block of the transcriptional activity of the sperm
DNA [65]. The complex mechanism of histone–protam-
ine transition is a finely regulated multi-step process. In
the first step, the histones in round spermatids are
replaced by a heterogeneous group of nuclear proteins
(transition proteins (TP)), as the result of histone hypera-
cetylation [66] (Fig. 1). The second step takes place in
elongating spermatids, determining the replacement of
TP1 and TP2 with protamines [62, 67] (Fig. 1). Protamines
have different functions: they allow the compaction of the
nucleus ensuring the genetic integrity of the sperm and
play an important role in epigenetic imprinting [62].
Mature spermatid nuclei present two types of protamines:
the P1 protamine and the P2 family of protamines, consti-
tuted by P2 (the most abundant), P3, and P4 members.
P1/P2 ratio appears to be critical for male fertility [68, 69].
In fact, the P1/P2 ratio, which in fertile males is close to 1
(range 0.8–1.2), is altered in infertile patients [69, 70].
Patients with a P1/P2 ratio <0.8 present inadequate DNA
condensation and important alterations in sperm
parameters, such as motility, counts, and structure
[68–71]. Moreover, Aoki et al. demonstrated that low
P1/P2 ratios are also associated with an increased
DNA fragmentation, which is also inversely correlated
with global sperm P1 and P2 concentrations, suggest-
ing a protective role of the protamines against sperm
DNA damage [72]. There is also evidence that subfer-
tility can be correlated with an excess of protamine P2
precursors (pre-P2), determined by an alteration of
the process leading to the mature protamine P2
formation [68, 71, 73, 74].
DNA methylation and histone modifications during
spermatogenesis
Various and specific epigenetic marks are required
during male gametogenesis for proper maturation of
gametes. In fact, before meiosis, the first epigenetic
events take place in the form of progressive demethyla-
tion–remethylation of DNA. During meiosis, DNMT3A,
DNMT3B, and cofactor DNMT3L activity regulates the
levels of de novo DNA methylation, completing this
process after birth at the stage of pachytene sperm-
atocyte [75]. Subsequently, the methylation profile is
maintained by DNMT1 activity. In addition to the
above-described processes, also histone modifications
(methylation and acetylation) occur, which modify
DNA accessibility to transcription factors (Fig. 1). In
fact, specific enzymes such as histone methyltransfer-
ase (HMT) and histone demethylase (HDM) regulate
lysine 9 of histone H3 (H3-K9) and lysine 4 of his-
tone H3 (H3-K4) methylation patterns. Generally,
histone H3-K9 methylation is high in meiosis but is
removed at the end of this process, promoting gene
activation, whereas histone H3-K4 methylation, which
decreases during meiosis, is associated to DNA silen-
cing [50] (Fig. 1). In addition, during spermatogenesis,
several enzymes, such as HAT and HDAC, regulate
the processes of acetylation and deacetylation of H3
and H4 lysine residues. During spermiogenesis, hyper-
acetylation of H4 plays a crucial role for correct his-
tone to protamine transition and allows nucleosome
disassembly in elongating spermatids [66, 76] (Fig. 1).
Epigenetic alterations and spermatogenesis disruption
The above-described epigenetic marks in germ line
genes play a key role in the proper spermatogenesis pro-
cesses, and several studies have demonstrated that aber-
rant epigenetic modification of genes expressed in the
testes are associated with male infertility. Navarro-Costa
et al. for the first time hypothesized that one of the fac-
tors of male gametogenic defects could be represented
by epigenetic alterations of specific genes, evidencing
increased methylation defects of the germ line regulator
DAZL gene in different quality-fractioned sperm popula-
tions of oligoasthenoteratozoospermic (OAT) patients as
compared to normozoospermic (NZ) men [77]. On the
contrary, no variation in the methylation state of the
DAZL gene promoter between NZ e OAT men was
observed. This study also highlighted the existence of
homogeneous DAZL methylation levels when comparing
the normal sperm-enriched fractions of NZ men. This
evidence has been subsequently confirmed on a larger
scale by Krausz et al. who detected no differences in the
DNA methylation status of several genes in the different
sperm subpopulations of normozoospermic individuals
[78]. Subsequently, other studies have identified more
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genes whose epigenetic modifications are related to alter-
ation of both semen parameters and fertility maintenance.
Hammoud et al., by analyzing seven imprinted loci (LIT1,
MEST, SNRPN, PLAGL1, PEG3, H19, and IGF2), corre-
lated alterations in the DNA methylation pattern of oligo-
zoospermic patients with abnormal protamine levels [70].
Interestingly, alterations in the mRNA levels of the genes
involved in the histone–protamine transition have been
evidenced also by studies carried out by investigating the
global testis transcriptome of normal and oligozoospermic
patients by microarray analysis [79]. Other studies have
demonstrated that DNA hypermethylation of the pro-
moter of several genes (such as MTHFR, PAX8, NTF3,
SFN, HRAS, RASGFR1, GTL2, PLAG1, D1RAS3, MEST,
KCNQ1, LT1, SNRPN and others) plays a critical role in
male infertility, being associated to alterations of sperm
concentration, motility, and morphology, while hypome-
thylation of the IGF2/H19 imprinting control region 1
(ICR1) has been detected in patients with low concentra-
tion and sperm motility as compared to normozoospermic
controls [70, 80–86].
Due to the increased knowledge about the epigenetic
alterations occurring in sperm DNA of infertile patients,
it has become clear that specific errors in the processes
of epigenetic control may occur during each stage of
spermatogenesis, adversely affecting male fertility and
embryonic development [49]. In fact, epigenetic alter-
ations occurring in mitosis can affect the expression of
specific genes involved in the first steps of spermatogen-
esis, leading to a decreased efficiency of the process.
When the meiotic stage is involved, these alterations can
induce double-strand breaks or chromosomal non-
disjunction. Finally, during spermiogenesis, epigenetic
alterations can involve histone-to-protamine transition
and histone removal and degradation, inducing protam-
ine replacement errors [49]. Taken together, all these
evidences suggest that different features of male infertil-
ity, such as alterations in sperm count or morphology,
DNA fragmentation, chromosomal aneuploidies, and al-
terations in the chromatin package, could be all related
to epigenetic mechanisms occurring at different stages
of spermatogenesis.
Epigenetics and embryo development
DNA methylation and histone modifications play a crucial
role in the process of genome reprogramming during early
embryogenesis [87–89]. Preimplantation embryo develop-
ment is a dynamic process characterized by deep gene
expression profile change and modifications in the
histone and chromatin organization [87, 90–92]. After
fertilization, the genome of paternal and maternal
origin is subjected to a process of reprogramming: at
first, the male pronucleus is demethylated [93, 94], and
after the formation of the zygote, the chromosomes of
both parents are demethylated by a passive mechanism
erasing most parts of the methylation marks except those
involved in the process of genomic imprinting [95]. The
methylation of imprinted genes is erased only in PGC,
cells of epiblast that give rise to male and female gametes.
Here, an extraordinary epigenetic regulation occurs in the
early stages of embryonic development, when the methy-
lation is erased and specific genes of pluripotency (OCT4
and NANOG) are expressed. De novo methylation starts
in the inner cell mass of the blastocyst and the levels of
methylated DNA increase in primitive ectoderm, while
methylation is inhibited in the trophoblast and in the
primitive endoderm [96, 97]. This alternation of demethyl-
ation and remethylation can be explained by the necessity
during preimplantation to activate zygotic genes essential
for early development, while de novo methylation could
establish a state of global silencing in order to suppress
retrotransposons [87]. In post-implantation embryos, the
maintenance of DNA methylation is crucial for embryonic
development. In female embryos, X inactivation, due to
increased expression and accumulation of Xist RNA,
occurs [98]. The X chromosome is inactivated to compen-
sate the number of X-linked genes in males and females,
and the process of inactivation takes place after the
implantation of female embryos or during the process of
differentiation of ESCs [99, 100]. A reactivation of the X
chromosome occurs in the inner cell mass of the blasto-
cyst and in the epiblast, followed by a random inactiva-
tion, a biological process in which both X chromosomes
have the same probability of being inactivated [101, 102].
A first relevant role played by paternal genome in the
above-described process is represented by genomic
imprinting. In fact, at least three paternally imprinted
genes, H19-IGF2, RASGRF, and DLK1-GTL2 are consid-
ered among the most relevant for embryonic develop-
ment and placentation [103–105]. However, genomic
imprinting does not appear to represent the only mech-
anism of paternal control on embryo development. As a
matter of fact, it has been demonstrated that the pres-
ence of modified histones in the spermatozoa could
represent a potential paternal contribution in epigenetic
reprogramming of the zygote regardless of the imprint-
ing process [106–108]. In fact, despite the exchange of
histones with protamine is essential for the maturation
of sperm, a residual percentage of genome (5–15 %) re-
tains the nucleosomal organization [109]. These retained
nucleosomes play a key role in the contribution of the
paternal genome in embryonic development [110]. In
fact, the paternal DNA packaging in spermatozoa seems
to have a potential role in transmitting an epigenetic
profile to the zygote in early embryogenesis [111], since
the nucleosome retention takes place in hypomethylated
regions corresponding to the promoters of developmen-
tal transcription and signaling factors which are the
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target of transcription factors such as OCT4, NANOG,
SOX2, and KLF4 [110]. In this view, it is possible to
hypothesize that an alteration of the correct distribution
of nucleosome retention within sperm DNA could
produce an impairment of embryo development. As a
matter of fact, Hammoud et al. demonstrated the pres-
ence in infertile men of randomly distributed histone
retention genome-wide, with alteration of the methyla-
tion status of candidate developmental promoters and
imprinted loci [111]. Moreover, genes in histone-bound
regions appear more susceptible to DNA damage in-
duced by smoking, obesity, and aging as compared to
protamine-bound regions, due to the incapacity of
sperm to repair DNA damage [112]. Histone-bound
regions play a crucial role in the activation of paternal
genome transcription in the early embryo, since while
paternal protamines are replaced by maternal histones
in the first 4 to 6 h after fertilization, this does not
occur for paternal histones, which are thus likely
inherited by the embryo [113]. Thus, the reported
data above suggest that, in some instances, epigenetic
defects of the sperm could induce not only a poor
sperm quality, but also a decreased ability of develop-
ment of the generated embryo after the fusion of the
gametes, providing a possible explanation for a num-
ber of early pregnancy loss after both in vivo and in
vitro fertilization.
Epigenetics and ART
A large amount of literature data, including human and
animal studies, has raised concerns about an increased
risk of different diseases in the offspring generated by
the use of ART [114, 115]. Several evidences have
suggested that the majority of these abnormal conditions
are related to epigenetic alterations.
Data from ART in animal models
Early studies carried out in mice had showed that alter-
ations affecting the development and growth of the
fetuses were linked to ovulation induction, manipulation
of eggs, or embryo culture in vitro [116–119]. A con-
firmation came from Khosla et al. showed that preim-
plantation mouse embryos cultured in the presence of
serum can change the expression and methylation of
several imprinted genes (such as H19, IGF2, GRB10, and
GRB7) and that these aberrant epigenetic modifications
lead to abnormal fetal growth in ART animals [120].
Moving to different animal models, Young et al. evi-
denced the presence of the “large offspring syndrome”
(LOS) (large size at birth, increased birth weight,
breathing difficulties, reluctance to suckle, and sudden
perinatal death) in sheep and cattle derived from
cultured embryo [121]. Subsequently, the pathogenesis
of LOS was suggested to be associated with epigenetic
abnormalities, leading to loss of imprinting and over-
expression of IGF2 receptor gene [122, 123]. Factors in
the ART procedures, triggering these imprinting errors,
were not clearly identified, but the onset of the
syndrome appeared to be dependent by in vitro culture
conditions [122, 123].
Data from ART in human
In human, a larger prevalence of syndromes related to
imprinting alteration, particularly Beckwith-Wiedemann
and Angelman syndromes, has been reported in children
born after ART when compared to non-ART children
[124–126]. Interestingly, the phenotype of Beckwith-
Wiedemann syndrome, an overgrowth condition char-
acterized by large size at birth, macroglossia, and
visceromegaly, closely remembers the previously de-
scribed LOS in cows and sheep generated by in vitro
fertilization, suggesting a common mechanism of ori-
gin of these conditions. On the other hand, also a
disproportionate number of low birth weight cases has
been observed in ART children [127].
The association between ART and altered DNA
epigenetic profiling has been demonstrated also by stud-
ies based on the analysis of the methylation status of
CpG sites in the promoters of 700 genes of placenta and
cord blood obtained from children conceived in vitro
and in vivo [128]. This analysis showed hypomethylation
of most CpG sites in the placenta and hypermethylation
of most CpG sites in cord blood in the group of children
conceived by in vitro fertilization as compared to natur-
ally conceived children. Interestingly, the genes showing
different expressions in the two groups appeared to be
involved in chronic metabolic disorders including obes-
ity, type II diabetes, and high blood pressure [128].
These data are in agreement with other studies reporting
an increased risk of disturbs in body fat composition,
changes in blood pressure, and increase in the late
infancy growth velocity in children generated by ART
procedures as compared to control children [129–131].
In addition, other studies showed a high risk of obes-
ity or type II diabetes in adult life in children gener-
ated by ART [132]. These results strongly suggest
that the effect of ART procedures could be mani-
fested not only at birth, but also in late infancy or
even in adult life.
As in animal models, the in vitro culture conditions
have been suggested as a main cause of epigenetic
defects in the offspring generated by ART also in human
[133]. In addition, it has been proposed that the low
birth weight observed after ART, as well as in small for
gestational age and very premature children, is the result
of an unfavorable embryonic, fetal, or neonatal environ-
ment, involving also epigenetic mechanisms, potentially
related to metabolic alterations in late childhood [134].
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However, several evidences have suggested that a
crucial role could be also played by epigenetic defects
in the sperms used in ART protocols. In fact, several
authors suggested that DNA methylation changes at
imprinted loci are inherited from the sperm of men
with oligozoospermia [82, 135, 136]. This could sug-
gest that the increase of DNA methylation variations
in ART depends, at least in part, on the presence of
epigenetic defects of male gamete. In this view, some
authors have proposed the possible usefulness of ana-
lyzing the imprinting methylation status in the rou-
tine sperm examination for ART treatment [136].
Moreover, it has been hypothesized that the use of
sperms with an abnormal P1/P2 ratio or defects of
histone–protamine may be responsible of imprinting
diseases in the offspring conceived with ART [50].
Unfortunately, this argument remains poorly under-
stood, as demonstrated by other studies reporting that
epigenetic abnormalities detected in sperms of oligo-
zoospermic patients do not appear to be associated
with ART outcome, suggesting that further studies
are required in order to shed light on the relationship
between sperm epimutation and alterations in chil-
dren generated by ART [137].
Environmental agents inducing epigenetic modifications
Several environmental and lifestyle factors (stress, phys-
ical activity, alcohol intake, smoke, shift work) are
known to affect male and female fertility [138], and in
many cases, they have been shown to influence the
occurrence of epigenetic modifications with implica-
tions for human diseases [139]. The presence of an en-
vironmental epigenetic inheritance through gametes
has been evidenced by studies carried out on different
animal models [140]. A few studies have suggested that
food or physical activity can influence histone modifica-
tions and miRNA expression. Dashwood et al. demon-
strated that a single intake of cruciferous vegetables
inhibits HDAC activity in mononuclear cells of periph-
eral blood promoting H3 and H4 acetylation [141],
while other studies demonstrated that exposure to
cigarette smoke causes a down-regulation of mir-34b,
mir-421, mir450-b, mir-466, and mir-469 [142]. Any-
way, the largest body of evidence comes from studies
investigating the environmental effects on DNA methy-
lation. Alterations in this process have been demon-
strated to be induced in specific genome regions by
toxic chemicals, high intake of alcohol and mother’s
diet, or smoking during intrauterine life [143, 144].
Further information in this field has been provided by
studies investigating the role played by paternal expo-
sures to various pollutants and lifestyle-related condi-
tions on the health status of the offspring and of the
future generations.
Paternal exposure to toxins or ionizing radiation
Great attention has been devoted to the effects of pater-
nal exposures to environmental toxins or low-dose
ionizing radiation, and of paternal lifestyle [145]. Several
studies had previously demonstrated the presence of a
strong association between paternal occupational expo-
sures to chemicals and harmful health outcomes in the
offspring. Feychting at al. demonstrated an increased risk
of nervous system tumors related to paternal occupa-
tional exposure to pesticides and of leukemia related to
woodwork by fathers [146]. Reid et al. evidenced the
presence of high exposure to exhausts by paternal
grandmothers of children with acute lymphoblastic
leukemia [147]. However, many of these conditions are
likely related to the presence of mutations in sperm
DNA, thus representing a genetic, rather than epigen-
etic, mechanism. Is there any evidence supporting the
presence of epigenetic mechanism driving the effects to
the offspring of the paternal exposure to chemicals?
Once again, the most relevant data in support of this
hypothesis come from studies on animal models, show-
ing that male exposure to pesticides or other harmful
chemicals can be responsible for defects in the gametes
and abnormal development of the offspring mainly via
altered DNA methylation patterns in the germ line
[148, 149]. Anway et al. evidenced that a transient em-
bryonic exposure to the endocrine disruptor vinclozolin
during gonadal sex determination in rats produced several
diseases affecting the prostate, kidney, immune system,
testis, as well as different cancers in the subsequent gener-
ations, suggesting a potential transgenerational effect
[148]. Similar results were obtained by Guerrero-Bosagna
et al., who showed that transient exposure of the F0
generation gestating female to vinclozolin during
gonadal sex determination caused adult onset disease
in the F3 generation male and female mice [149].
Also, ionizing radiations have been recently invoked as
a risk factor for alterations of DNA methylation. These
radiations trigger a series of processes on the cells as
genotoxic alterations including DNA breaks, but the
actual mechanism leading to a transgenerational effect is
still poorly understood. Dubrova et al. suggested an
epigenetic mechanism of transmission of the radiation-
exposure signal through sperm, likely involving DNA
methylation and affecting DNA repair processes [150].
These authors suggested that the persistence of instabil-
ity into the germ line of unexposed offspring of irradi-
ated mice could be responsible of mosaicism in germ
cells, a well-known mechanism in the origin of human
genetic disorders [150].
More recently, it has been suggested that a crucial
role in transgenerational radiation effects, such as
genomic and epigenomic instability, could be played by
the Piwi-interacting RNAs (piRNA) pathway, involved
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in the maintenance of genomic stability by facilitating
DNA methylation of transposable elements and also
implicated in other epigenetic alterations affecting a
variety of cellular regulation processes [151]. Another
experiment on animal models supports transgenera-
tional epigenetic changes as a result of parental expos-
ure to genotoxic stressors, as irradiation, nutrition, and
intake of anti-androgen compounds [152]. For example,
it has been demonstrated that treatment with the anti-
androgen compound vinclozolin on female mice in-
duces epigenetic effects in the sperm of their offspring
as compared to controls [153]. This study highlighted
an increased methylation of the differentially methyl-
ated domains (DMDs) of maternal PEG1, PEG3, and
SNRPN genes and decreased methylation of paternal
H19 and GTL2 genes.
Paternal diet
One of the most intriguing topics in the field of epigen-
etic modifications of the germ line is represented by the
influence played by the paternal diet on gametogenesis.
The first evidences of this association came from animal
models. Carone et al. demonstrated that male mice fed
with low-protein diet generated an offspring showing an
increased expression of genes involved in the synthesis
of lipids and cholesterol, as compared to the offspring of
control male mice fed with a normal diet. Based on
these results, authors suggested that cholesterol and
lipid metabolism in an offspring can be strongly affected
by paternal diet [154]. This study was carried out by a
whole-genome characterization of cytosine methylation
patterns and RNA content in sperm obtained from mice
submitted to low-protein or caloric restriction diets and
controls. Authors detected similar cytosine methylation
patterns in all three conditions, thus suggesting that the
sperm epigenome is largely unaffected by these diets and
that changes in relatively few loci can have profound
effects in the developing animal [154]. However, in a
more recent study, Radford et al. demonstrated that in
utero undernourishment perturbs the adult sperm
methylome, suggesting that alterations in gamete methy-
lation could induce alterations in chromatin architec-
ture, transcriptional networks differentiation, or tissue
structure, and in turn is able to contribute to the inter-
generational transmission of environmentally induced
diseases [155].
In another animal study, Ng et al. showed the pres-
ence of pancreatic alterations, with early onset impaired
insulin secretion and glucose tolerance worsening with
time, in the female offspring of male mice fed with a
high-fat diet [156]. This effect was mediated by the
altered expression in adult female offspring of 642 pan-
creatic islet genes, belonging to 13 functional clusters,
including cation and ATP binding, and cytoskeleton
and intracellular transport. Fullston et al. demonstrated
the presence of altered global methylation in mature
sperm and abnormal testis transcription of male mice
consuming a high-fat diet, with metabolic disturbances
in the next generations [157]. In addition to experimen-
tal data on animal models, very interesting data about
the role played by diet on the epigenetic modifications
and on the consequent transgenerational effects are
available in human as well. During the winter of 1944–45
of World War II, in the Netherlands, as a reprisal against
the activity of the Dutch government-in-exile aimed to
disrupt the transport of German reinforcements and
troops, the Germans banned all food and fuel transports
to Netherlands, inducing a severe famine, with the official
daily rations for the general adult population decreasing
gradually from about 1800 calories (December 1943) to
below 800 calories (April 1945). The situation improved
in a very short time after the liberation of the Netherlands
on May 1945, with the rations raising up to over 2000
calories a day by June 1945 [158]. The famine caused a
severe mortality in the population of Amsterdam, but
nevertheless, several babies were conceived and birthed
during that period. Several decades later, a number of
studies investigated the health status of people born in
Amsterdam during the famine period in order to shed
light on the effects of malnutrition on the health of the
offspring in adult life. In a first time, these studies
evidenced an association with chronic diseases in adult life
in the offspring (coronary heart disease, atherogenic lipid
profile, obesity, raised levels of plasma fibrinogen, and
decreased levels of factor VII), strongly related to the
timing in gestation of exposure to famine [158, 159]. How-
ever, by analyzing the results of these epidemiological
studies with the aid of molecular tools, it has become clear
that the Dutch famine families study has provided the first
direct evidence for epigenetic programming through
prenatal famine exposure. In fact, it was clearly demon-
strated that periconceptional exposure to famine pro-
duced an under-methylation (likely related to a deficiency
in methyl donors) in the differentially methylated region
(DMR) of the maternally imprinted IGF2 gene [160],
suggesting that early undernutrition can cause epigenetic
changes persisting throughout life. On the other hand,
there was no variation in IGF2 methylation status in
individuals exposed to famine in later gestation.
Further studies evidenced that persistent changes in
DNA methylation represent a common consequence
of prenatal famine exposure and that they can be
affected by the sex of the exposed individual and the
gestational timing of the exposure [161]. More recently, it
has been demonstrated that prenatal malnutrition-
associated DMRs (P-DMRs) mostly occur in regulatory
regions of genes showing differential expression during
early development [162].
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All the above-reported studies suggest that undernu-
trition plays a direct effect on the fetus during the early
phases of development. However, why should we exclude
that the target of the famine could be represented also
by gametes other than by embryo? Several evidences
strongly suggest a role played by paternal diet on the
healthy status of children, as confirmed by the above-
described results on animal models. In human, the link
between grandparental nutrition and grandchild’s growth
was at first examined by Bygren et al., who demon-
strated that a surfeit of food in the environment when
the paternal grandfather was a boy was related to a
shortening of the proband survival [163]. The same
group subsequently demonstrated that a limited avail-
ability of food during the father’s prepuberal age was
related to a low cardiovascular disease mortality of the
proband, while paternal grandfather exposure to a surfeit
of food during the same period was related to increased
diabetes mortality in the proband [164], suggesting
epigenetic inheritance as a strong candidate for these
phenomena [165]. Soubry et al. demonstrated the pres-
ence of alterations in the methylation status at multiple
imprint regulatory regions in children with obese par-
ents, suggesting a preconceptional influence of parental
lifestyle and nutrition on the programming of imprint
marks during gametogenesis [166]. In particular, the
significant association between paternal obesity and
altered methylation in the offspring suggests the sus-
ceptibility of the developing sperm to environmental
insults. Very recently, the evidence of a role played by
changes in paternal grandmothers’ early food supply on
the risk of cardiovascular mortality of the female grand-
children have also suggested an X-linked epigenetic
inheritance via spermatozoa [167]. However, it has also
been stressed that a true transgenerational inheritance
in response to diet should be examined on the third
generation, which represents the actual first “unex-
posed” one, being the first filial generation directly
exposed to the maternal diet, and deriving the second
from gametes exposed in utero [168]. Despite these
limitations, the possible presence of transgenerational
effects related to the epigenetic effect of paternal diet
remains a very interesting topic.
The four windows of epigenetic susceptibility
A crucial question concerning the role played by envir-
onmental agents in the epigenetic modifications of the
male gamete is the following: when are the effects of
such exposures transferred to the male gamete? Soubry
et al. identified four potential windows of susceptibility
during the development of the paternal germ line and
zygote [145]. The first window is represented by paternal
embryonic development, when PGC undergo genome-
wide epigenetic erasure during migration to the genital
ridge. Defects in this process, as well as in the mainten-
ance of some protected regions, could be caused by
internal or external factors during early development.
The second window is represented by paternal pre-
puberty, since in this period, de novo methylation at
imprinted gene loci occurs. The third window can be
identified in the period in which spermatogenesis, and in
particular the development from spermatogonium to
spermatocytes, occurs, since methylation patterns are
established during this time. This window appears to be
a very important one, representing the reproductive
period of the subject, when a careful evaluation of his
lifestyle, with prevention of environmental stressors,
could be used as a preventive strategy. Finally, the fourth
window is represented by the periconception period and
the zygote stage, when histone retention in certain genes
could represent a potential mechanism for inheritance of
environmentally induced epigenetic marks. While stud-
ies investigating the effect of environmental agents in
the latter three windows are currently carried out,
mostly on animal models but also in humans, it is more
difficult to investigate epigenetic modifications in PGCs.
However, the recently reported discovery that amniotic
fluid stem cells (AFSCs) share a number of features with
PGCs [169] provides a novel cellular model for the study
of the effect played by environmental agents in altering
the epigenetic processes occurring in these cells, opening
new scenarios in this field of study.
Finally, it must be stressed that aging represents
another possible risk factor for epigenetic modifica-
tions increasing the risk of neuropsychiatric disorders
such as autism and schizophrenia. Jenkins et al. have
recently identified 139 regions significantly and
consistently hypomethylated and 8 regions signifi-
cantly hypermethylated with aging, with a total of 117
genes involved [170]. These authors evidenced that a
portion of the age-related changes in sperm DNA
methylation involves genes previously associated with
schizophrenia and bipolar disorder.
Conclusions
As evidenced by the large amount of studies carried out in
this field, epigenetic mechanisms play a key role in the
proper function of the male gamete, and alterations in
these mechanisms can widely affect human reproduction.
The effect of epigenetic modification of sperm gene func-
tion can affect the reproductive outcome in at least four
different levels: (1) impairment of male fertility due to
alterations in sperm number and morphology; (2) alter-
ations of embryo development; (3) poor outcome of the
ART protocols; and (4) risk of pathologies in the adultness
for the offspring (Fig. 2). Due to the huge interest devoted
to this topic by the scientific community, related to the
possible implications in the field of human reproduction
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and health, our knowledge about the above-discussed
mechanisms are increasing day by day. Recent studies
have highlighted the molecular mechanisms underlying
the epigenetic transgenerational inheritance of some
disease. Guerrero-Bosagna et al. have demonstrated the
presence of unique consensus DNA sequence motifs,
zinc finger motifs, and G-quadruplex sequences in
transgenerational DMR in sperm, which, by the inter-
action of molecular factors, could induce alterations of
the chromatin structure and accessibility of proteins
with DNA methyltransferases altering de novo DNA
methylation patterns [171].
It can be suggested that in the next future, the study
of epigenetics and epigenomics will likely represent a
crucial step in the diagnostic workup of the infertile
male, especially in cases submitted to ART, where it will
be necessary to select adequately functional sperm to
avoid the epigenetic alteration impact on the procedure.
So far, the application of the analysis of epimutations in
the male gamete in the clinical practice is hampered by
the lack of complete information about the involved
genes and by the use of expensive, low-throughput tech-
niques. However, due to the large number of ongoing
studies in this field, a clearer picture of the situation
should be available in a short time, and the set-up of
specific assays will likely reduce the costs and the time
of these analyses. Further information will likely be
provided by studies investigating the role played by
sperm non-coding RNA in male fertility, which repre-
sents a very promising field of study [172]. Another very
exciting field is represented by the potential role played
by the non-sperm fraction of the seminal fluid, since
postejaculatory effects on sperm survival and functional
competence have been reported [173]. Surprisingly,
seminal plasma may affect offspring independently of
sperm, by stimulating the production of embryotrophic
cytokines and growth factors by the female reproductive
tract [173]. The alteration of this process induces abnor-
mal fat deposition and metabolic phenotype in the
offspring, particularly in the males [174]. Finally, great
attention should be devoted to the role played by envir-
onmental agents both in determining and in repairing
epigenetic alterations. In fact, the identification of the
specific doses and times of action of agents able to
induce epigenetic alteration of sperm DNA or to restore
the functional conditions will be likely of great help in
the treatment of spermatogenetic defects and/or poor
outcome of both normal and in vitro fertilization.
Most importantly, the possibility that paternal lifestyle
could affect the health of the offspring during lifetime
opens a novel and exacting scenario in the prevention
of common, late onset diseases [175].
Fig. 2 Epigenetic alterations induced by lifestyle and environmental factors (diet, smoking, radiation, alcohol consumption, etc.) can
have substantial effects on the sperm function. As a first consequence, these modifications can induce sperm alterations leading to
impairment of male fertility. When fertilization occurs, spontaneously or by ART, transgenerational epigenetic effects can be observed,
in details leading to (1) alterations of embryo development, (2) congenital diseases at birth, and (3) late onset diseases (obesity,
hypertension, diabetes, etc.) in the adult life
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